Moran Ja, Neligan A
J Med Case Rep. 2009 May 8;3:7229. doi: 10.1186/1752-1947-3-7229.
Treatment-resistant trigeminal neuralgia is a distressing condition, for both the patient and the treating doctor. To our knowledge, there are no reported cases of trigeminal neuralgia successfully treated with oral sumatriptan in the literature.
A 51-year-old Caucasian woman was prescribed opiate analgesia for management of her treatment-resistant trigeminal neuralgia. Given the possible harmful effects of initiating such a course of treatment, a speculative therapeutic trial with oral sumatriptan was initiated with a successful outcome.
This case raises the hypothesis that oral sumatriptan may be an effective drug in the treatment of trigeminal neuralgia. Further research is required to test this theory.
难治性三叉神经痛对患者和治疗医生来说都是一种痛苦的病症。据我们所知，文献中尚无口服舒马曲坦成功治疗三叉神经痛的报道病例。
一名51岁的白种女性因难治性三叉神经痛而被开具阿片类镇痛药进行治疗。鉴于启动此类治疗过程可能产生的有害影响，遂启动了口服舒马曲坦的探索性治疗试验，结果取得成功。
本病例提出了一种假设，即口服舒马曲坦可能是治疗三叉神经痛的有效药物。需要进一步研究来验证这一理论。
